BIOMAT Database Logo BIOMAT Database Logo

[Bacterial etiological factors and the treatment of pneumonia in hospitalized patients]. 1977

E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
Etiological factors in non-bacterial pneumonia.
May 1955, Canadian services medical journal,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
[Prognostic and risk factors in patients hospitalized with bacterial pneumonia].
May 2007, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
[Bacterial etiological factors of diarrhea in the stool of infants hospitalized in January 1987].
January 1989, Przeglad epidemiologiczny,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
Risk factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia in a Chinese population.
September 2013, QJM : monthly journal of the Association of Physicians,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
Prognostic factors in patients hospitalized with pneumonia.
August 1995, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
[CERTAIN CLINICAL AND ETIOLOGICAL PROBLEMS IN BACTERIAL PNEUMONIA].
October 1963, Terapevticheskii arkhiv,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia.
January 1990, The Journal of international medical research,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
[Community acquired pneumonia in a hospitalized community: etiological study].
May 2003, Revista medica de Chile,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study.
April 2000, Chest,
E Bek-Lissner, and H Bergson, and J Graczyk, and A Kucharska
[Etiological factors of community acquired urinary tract infections in hospitalized patients].
January 2009, Medicinski arhiv,
Copied contents to your clipboard!